A novel SLC1A1-RIC1 fusion sensitive to asparaginase-based therapy in natural killer/T-cell lymphoma. Xiong J, Zhao WL. Br J Haematol 2023 Sep 1. doi: 10.1111/bjh.19066.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiong J, Zhao WL. A novel SLC1A1-RIC1 fusion sensitive to asparaginase-based therapy in natural killer/T-cell lymphoma. Br J Haematol 2023 Sep 1. doi: 10.1111/bjh.19066.
PMID: 37658626